candesartan has been researched along with Anoxemia in 3 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Since we have proposed that perturbation of the interstitial capillary circulation with consequent chronic hypoxia could be critical to the progressive nature of many renal diseases, we developed a dynamic method of measuring renal cortical pO(2) and sought to determine whether agents which block the renal effects of angiotensin II (AII) could affect interstitial microvascular oxygenation in the normal rat kidney." | 3.72 | Angiotensin II blockade augments renal cortical microvascular pO2 indicating a novel, potentially renoprotective action. ( Fine, LG; Norman, JT; Singer, M; Stidwill, R, 2003) |
| "Administration of enalaprilat and candesartan did not affect the Ppa-Ppao gradient at baseline or during hypoxia." | 3.72 | Endogenous angiotensin II in the regulation of hypoxic pulmonary vasoconstriction in anaesthetized dogs. ( Bergmann, P; Biarent, D; Hubloue, I; Kerbaul, F; Leeman, M; Milani, GM; Naeije, R; Rondelet, B; Staroukine, M, 2004) |
| "Hypoxia caused by sleep apnea might be associated with an increased risk of cardiovascular events in subjects with metabolic syndrome." | 1.33 | Angiotensin-II receptor blocker exerts cardioprotection in diabetic rats exposed to hypoxia. ( Furuya, E; Hayashi, T; Inamoto, S; Kitaura, Y; Matsumura, Y; Mori, T; Nakano, D; Okuda, N; Sakai, A; Sohmiya, K; Tazawa, N; Yamashita, C, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Norman, JT | 1 |
| Stidwill, R | 1 |
| Singer, M | 1 |
| Fine, LG | 1 |
| Hubloue, I | 1 |
| Rondelet, B | 1 |
| Kerbaul, F | 1 |
| Biarent, D | 1 |
| Milani, GM | 1 |
| Staroukine, M | 1 |
| Bergmann, P | 1 |
| Naeije, R | 1 |
| Leeman, M | 1 |
| Inamoto, S | 1 |
| Hayashi, T | 1 |
| Tazawa, N | 1 |
| Mori, T | 1 |
| Yamashita, C | 1 |
| Nakano, D | 1 |
| Matsumura, Y | 1 |
| Okuda, N | 1 |
| Sohmiya, K | 1 |
| Sakai, A | 1 |
| Furuya, E | 1 |
| Kitaura, Y | 1 |
3 other studies available for candesartan and Anoxemia
| Article | Year |
|---|---|
Angiotensin II blockade augments renal cortical microvascular pO2 indicating a novel, potentially renoprotective action.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; | 2003 |
Endogenous angiotensin II in the regulation of hypoxic pulmonary vasoconstriction in anaesthetized dogs.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; A | 2004 |
Angiotensin-II receptor blocker exerts cardioprotection in diabetic rats exposed to hypoxia.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure | 2006 |